A Multi-centre, Non-comparative, Retrospective Post-market Surveillance Study to Obtain Clinical Outcomes Data on the Zimmer Avenir Müller Hip Stem
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Osteoarthritis, Hip
- Sponsor
- Zimmer Biomet
- Enrollment
- 150
- Primary Endpoint
- Evaluation of Pain and Functional Performance Determined by the Harris Hip Score
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
This study is a Post Market Clinical Follow up study to fulfil the post market surveillance obligations according to Medical Device Directive and European Medical Device Vigilance System (MEDDEV) 2.12-2. The data collected from this study will serve the purpose of confirming safety and performance of the Avenir Müller Hip Stem.
Detailed Description
The objective of this post market surveillance study is to obtain outcome data on the Avenir Müller Hip Stem by analysis of standard scoring systems, radiographs and adverse event records, and thus to assess the long-term performance and safety of this implant. This is a multi-centre, retrospective post-market surveillance study involving orthopaedic surgeons skilled in hip surgery. Each case enrolled has received the Avenir Müller Hip Stem for a primary hip arthroplasty. The Avenir Müller Hip Stem is CE marked (European Conformity) and commercially available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients able to participate in a follow-up program based upon physical examination and medical history.
- •Patients or patient's legal representatives who have given written consent to take part in the study by signing the 'Patient Consent Form'.
- •18 years minimum.
- •Male and female.
- •Baseline data exist (pre-, peri- and immediate postoperative)
Exclusion Criteria
- •Patients who are unwilling or unable to comply with the follow-up program.
- •Known pregnancy.
- •Patients who are skeletally immature.
Outcomes
Primary Outcomes
Evaluation of Pain and Functional Performance Determined by the Harris Hip Score
Time Frame: 10 years
The Harris Hip Score is a questionnaire filled by the surgeon with the patient who received a hip implant. The domains covered are pain, function, absence of deformity, and range of motion. The pain domain measures pain severity and its effect on activities and need for pain medication. The function domain consists of daily activities (stair use, using public transportation, sitting, and managing shoes and socks) and gait (limp, support needed, and walking distance). Deformity takes into account hip flexion, adduction, internal rotation, and extremity length discrepancy. Range of motion measures hip flexion, abduction, external and internal rotation, and adduction. There are 10 items. The score has a maximum of 100 points (best possible outcome) covering pain (1 item, 0-44 points), function (7 items, 0-47 points), absence of deformity (1 item, 4 points), and range of motion (2 items, 5 points).
Secondary Outcomes
- Survivorship of the Implant(10 years)
- Confirmation of Safety Based on Complications(up to 10 years)